WELL Health Technologies Beheer

Beheer criteriumcontroles 3/4

De CEO WELL Health Technologies is Hamed Shahbazi, benoemd in May2018, heeft een ambtstermijn van 6.5 jaar. De totale jaarlijkse vergoeding van { bedraagt CA$ 6.51M, bestaande uit 7.7% salaris en 92.3% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 5.97% van de aandelen van het bedrijf, ter waarde CA$ 76.80M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 5.6 jaar en 6.6 jaar.

Belangrijke informatie

Hamed Shahbazi

Algemeen directeur

CA$6.5m

Totale compensatie

Percentage CEO-salaris	7.7%
Dienstverband CEO	6.5yrs
Eigendom CEO	6.0%
Management gemiddelde ambtstermijn	5.6yrs
Gemiddelde ambtstermijn bestuur	6.6yrs

Recente managementupdates

Recent updates

When Should You Buy WELL Health Technologies Corp. (TSE:WELL)?

Nov 11

Is WELL Health Technologies (TSE:WELL) A Risky Investment?

Sep 09

Market Participants Recognise WELL Health Technologies Corp.'s (TSE:WELL) Revenues Pushing Shares 30% Higher

Jul 05

WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 60% Above Its Share Price

Jun 11

WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 43% Above Its Share Price

May 31

Analyse CEO-vergoeding

Hoe is Hamed Shahbazi's beloning veranderd ten opzichte van WELL Health Technologies's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	CA$73m
Jun 30 2024	n/a	n/a	CA$147m
Mar 31 2024	n/a	n/a	CA$30m
Dec 31 2023	CA$7m	CA$500k	CA$82k
Sep 30 2023	n/a	n/a	-CA$7m
Jun 30 2023	n/a	n/a	-CA$4m
Mar 31 2023	n/a	n/a	-CA$5m
Dec 31 2022	CA$2m	CA$450k	CA$1m
Sep 30 2022	n/a	n/a	-CA$29m
Jun 30 2022	n/a	n/a	-CA$37m
Mar 31 2022	n/a	n/a	-CA$45m
Dec 31 2021	CA$5m	n/a	-CA$44m
Sep 30 2021	n/a	n/a	-CA$29m
Jun 30 2021	n/a	n/a	-CA$21m
Mar 31 2021	n/a	n/a	-CA$9m
Dec 31 2020	CA$710k	n/a	-CA$4m
Sep 30 2020	n/a	n/a	-CA$9m
Jun 30 2020	n/a	n/a	-CA$10m
Mar 31 2020	n/a	n/a	-CA$8m
Dec 31 2019	CA$681k	n/a	-CA$8m
Dec 31 2018	CA$502k	n/a	-CA$2m

Compensatie versus markt: De totale vergoeding ($USD 4.66M ) Hamed } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Canadian markt ($USD 1.83M ).

Compensatie versus inkomsten: De vergoeding van Hamed is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Hamed Shahbazi (49 yo)

6.5yrs

Tenure

CA$6,508,755

Compensatie

Mr. Hamed Shahbazi, B. Sc., serves as Chairman & Chief Executive Officer at WELL Ventures. He is Chairman of the Board of Healwell AI Inc. from February 2024. He was Director of Healwell AI Inc. from Octob...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Hamed Shahbazi	Founder	6.5yrs	CA$6.51m	5.97% CA$ 76.8m
Eva Fong	Chief Financial Officer	5.6yrs	CA$1.15m	0.70% CA$ 9.0m
Amir Javidan	Chief Operating Officer	5.8yrs	CA$1.12m	0.80% CA$ 10.3m
James Kreger	CEO of WELL Health USA & CRH Medical	2.8yrs	CA$1.64m	geen gegevens
Beemal Shah	COO of CRH Medical Corporation	2.2yrs	CA$1.58m	geen gegevens
Pardeep Sangha	Vice President of Corporate Strategy & Investor Relations	5.6yrs	geen gegevens	geen gegevens
Brian Levinkind	Senior Vice President of Corporate Development	5.6yrs	CA$302.30k	geen gegevens
Chris Ericksen	Senior Vice President of Strategic Partnerships & Marketing	5.8yrs	geen gegevens	geen gegevens
Shane Sabatino	Chief People Officer	3.8yrs	geen gegevens	geen gegevens
Michael Frankel	Chief Medical Officer	6yrs	CA$639.73k	geen gegevens
Michael Goodman	Head of Acquisitions - Eastern Canada	4.3yrs	geen gegevens	geen gegevens
Iain Paterson	Chief Information Security Officer	2.5yrs	geen gegevens	geen gegevens

5.6yrs

Gemiddelde duur

55yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van WELL is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.6 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Hamed Shahbazi	Founder	8.7yrs	CA$6.51m	5.97% CA$ 76.8m
Thomas Liston	Independent Director	6.6yrs	CA$257.87k	0.26% CA$ 3.3m
Kenneth Cawkell	Independent Director	8.7yrs	CA$245.50k	0.18% CA$ 2.4m
John Kim	Independent Director	6.8yrs	CA$245.50k	0.15% CA$ 2.0m
Patricia Kirkpatrick	Member of Advisory Board	5.2yrs	geen gegevens	geen gegevens
Tara McCarville	Independent Director	4.6yrs	CA$245.50k	0.039% CA$ 498.1k
Sybil E. Lau	Independent Director	2.3yrs	CA$210.24k	0.20% CA$ 2.6m

6.6yrs

Gemiddelde duur

62yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van WELL wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.6 jaar).

WELL Health Technologies Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

Chief Operating Officer exercised options to buy CA$1.6m worth of stock.

WELL Health Technologies Corp., Annual General Meeting, Jun 12, 2024

Independent Director exercised options and sold CA$144k worth of stock

Independent Director recently sold CA$160k worth of stock

Founder exercised options and sold CA$527k worth of stock

Chief Financial Officer exercised options to buy CA$1.5m worth of stock.

Recent updates

When Should You Buy WELL Health Technologies Corp. (TSE:WELL)?

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

WELL Health Technologies Corp. (TSX:WELL) entered into definitive agreement to acquire Canadian Clinical Assets of Jack Nathan Health from Jack Nathan Medical Corp. (TSXV:JNH) for CAD 5 million.

WELL Health Technologies Corp. to Report Q3, 2024 Results on Nov 07, 2024

Ms. CHAU Hoi Shuen Solina Holly acquired a 7.53% stake in WELL Health Technologies Corp. (TSX:WELL) for CAD 81.01 million.

Is WELL Health Technologies (TSE:WELL) A Risky Investment?

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

WELL Health Technologies Corp. Revised Revenue Guidance for the Year 2024

Consensus EPS estimates increase by 827%

Consensus EPS estimates fall by 13%

WELL Health Technologies Corp. to Report Q2, 2024 Results on Aug 14, 2024

Market Participants Recognise WELL Health Technologies Corp.'s (TSE:WELL) Revenues Pushing Shares 30% Higher

Chief Operating Officer exercised options to buy CA$1.6m worth of stock.

New major risk - Revenue and earnings growth

WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 60% Above Its Share Price

WELL Health Technologies' (TSE:WELL) Earnings Are Weaker Than They Seem

WELL Health Technologies Corp. Revises Revenue Guidance for the Year 2024

WELL Health Technologies Corp. to Report Q1, 2024 Results on May 08, 2024

WELL Health Technologies Corp., Annual General Meeting, Jun 12, 2024

Well Health Technologies Corp. Raises Earnings Guidance for 2024

Full year 2023 earnings released: EPS: CA$0 (vs CA$0.006 in FY 2022)

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

WELL Health Technologies Corp. to Report Q4, 2023 Results on Mar 21, 2024

Is WELL Health Technologies Corp. (TSE:WELL) Trading At A 40% Discount?

Independent Director exercised options and sold CA$144k worth of stock

WELL Health Technologies Corp. Announces the Creation of A Dedicated Public Sector Group to Help Tech Enable Public Health Systems Operating At Scale

Healwell AI Inc. (TSX:AIDX) completed the acquisition of Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

Healwell AI Inc. (TSX:AIDX) entered into an agreement to acquire Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

The Price Is Right For WELL Health Technologies Corp. (TSE:WELL)

WELL Health Technologies Corp. announced that it has received CAD 0.074876 million in funding

Well Health Announces Launch of Well Ai Inbox Admin: A Revolutionary Ai-Powered Solution for Clinic Inbox Management

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Well Health Technologies Corp. Provides Earnings Guidance for the Year 2023 and 2024

Consensus EPS estimates upgraded to CA$0.08 loss

WELL Health Technologies Corp. Launches WELL Longevity+ Program

WELL Health Technologies Corp. to Report Q3, 2023 Results on Nov 14, 2023

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

Independent Director recently sold CA$160k worth of stock

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of Clinic assets from MCI Medical Clinics Inc.

Consensus estimates of losses per share improve by 22%

Second quarter 2023 earnings: EPS exceeds analyst expectations

WELL Health Technologies Corp. to Report Q2, 2023 Results on Aug 10, 2023

Founder exercised options and sold CA$527k worth of stock

WELL Health Technologies Corp. (TSX:WELL) entered into an agreement to acquire Significant Portion of Clinical Assets of MCI Medical clinics Inc.

Consensus EPS estimates fall by 11%, revenue upgraded

We Think WELL Health Technologies (TSE:WELL) Can Stay On Top Of Its Debt

Consensus EPS estimates fall by 11%, revenue upgraded

Well Health Technologies Corp. Provides Revenue Guidance for the Year 2023

Chief Financial Officer exercised options to buy CA$1.5m worth of stock.

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of MCI Medical Clinics (Alberta) Inc. from MCI Onehealth Technologies Inc. (TSX:DRDR).

Founder exercised options and sold CA$204k worth of stock

Consensus EPS estimates fall by 60%

WELL Health Technologies Corp. (TSX:WELL) entered into a definitive share purchase agreement to acquire MCI Medical Clinics (Alberta) Inc. from MCI Onehealth Technologies Inc. (TSX:DRDR) for CAD 2 million.

Consensus EPS estimates fall by 108%, revenue upgraded

WELL Health Technologies Corp. Provides Earnings Guidance for the Year 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

WELL Health Technologies Corp. Announces the Launch of Its Ground-Breaking Product, WELL AI Voice

WELL Health Technologies Corp. to Report Q1, 2023 Results on May 12, 2023

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

Full year 2022 earnings released: EPS: CA$0.006 (vs CA$0.23 loss in FY 2021)

Consensus EPS estimates fall by 77%

Are Investors Undervaluing WELL Health Technologies Corp. (TSE:WELL) By 40%?

Consensus estimates of losses per share improve by 24%

Forecast to breakeven in 2024

Forecast to breakeven in 2024

Third quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

WELL Health Technologies Corp. Increases Annual Revenue Guidance for 2022

Should You Think About Buying WELL Health Technologies Corp. (TSE:WELL) Now?

WELL Health Technologies Corp. to Report Q3, 2022 Results on Nov 10, 2022